Intellipharmaceutics International Inc. (IPCI)

[AngeloFoca]

http://www.investopedia.com/articles/stocks/06/biotechvaluation.asp?ad=dirN&qo=investopediaSiteSearch&qsrc=0&o=40186

The above link is full of info if you're not familiar with how the pie is split between partners.

If IPCI chooses to manufacture, which I'm sure it will, it will do so on a cost + basis... not at all uncommon in these type of partnerships.

You get estimates on what Rexista will cost to produce when scaled up, and add 20% to that - because everyone is allowed to make a profit - so if cost is $1.00 a pill, then IPCI sells it to it's partner for $1.20.